ADDAX Biosciences

Turin, Italy Founded: 2017 • Age: 9 yrs
Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields.
Request Access

About ADDAX Biosciences

ADDAX Biosciences is a company based in Turin (Italy) founded in 2017.. ADDAX Biosciences offers products and services including GAF. ADDAX Biosciences operates in a competitive market with competitors including GlyTech, Echelon Biosciences, Iceni Glycoscience, GlycoSpot and TFChem, among others.

  • Headquarter Turin, Italy
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    FT Partners

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ADDAX Biosciences

ADDAX Biosciences offers a comprehensive portfolio of products and services, including GAF. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Safe, non-toxic solution for preserving tissue in medical diagnostics.

Funding Insights of ADDAX Biosciences

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (01 Jan 2020)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2024 Amount Seed - ADDAX Biosciences Valuation FT Partners
Aug, 2020 Amount Grant - ADDAX Biosciences Valuation

investors

Jan, 2020 Amount Grant - ADDAX Biosciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ADDAX Biosciences

ADDAX Biosciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include FT Partners, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Investment banking services focused on fintech are provided.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ADDAX Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ADDAX Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Addax Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ADDAX Biosciences

ADDAX Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Echelon Biosciences, Iceni Glycoscience, GlycoSpot and TFChem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Human-type Asp-linked glycans are supplied for research applications.
domain founded_year HQ Location
Reagents and assays for lipid biology research are manufactured.
domain founded_year HQ Location
Glycoscience platform is provided for diagnostic and therapeutic applications.
domain founded_year HQ Location
High-throughput enzyme screening solutions are developed and provided.
domain founded_year HQ Location
Fluoride chemistry is utilized to design glycomimetic drug compounds.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Addax Biosciences

Frequently Asked Questions about ADDAX Biosciences

When was ADDAX Biosciences founded?

ADDAX Biosciences was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is ADDAX Biosciences located?

ADDAX Biosciences is headquartered in Turin, Italy. It is registered at Turin, Piedmont, Italy.

Who is the current CEO of ADDAX Biosciences?

Gianni Bussolati is the current CEO of ADDAX Biosciences.

What does ADDAX Biosciences do?

ADDAX Biosciences was founded in 2017 in Turin, Italy, within the biotechnology sector. A patented non-toxic fixative is developed as a substitute for formalin, enabling histological, immunohistochemical, and molecular analyses with reduced health risks. Operations focus on laboratory applications to enhance worker safety and patient outcomes. Collaborations with research institutions are maintained to expand technology uses across various fields.

Who are the top competitors of ADDAX Biosciences?

ADDAX Biosciences's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.

What products or services does ADDAX Biosciences offer?

ADDAX Biosciences offers GAF.

Who are ADDAX Biosciences's investors?

ADDAX Biosciences has 3 investors. Key investors include FT Partners, European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available